ArticleHaematologica2024

Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry.

Tommaso Francesco Aiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.